News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
The Clorox Company CLX is scheduled to report fourth-quarter fiscal 2026 results on Aug. 3, after market close, and is likely to have registered declines in the top and bottom lines. The Zacks Consensus Estimate for revenues is pegged at $1.91 billion, indicating a …
Sharemaestro market context Price above Trend Line 52 weeks -18.9% · Next-week setup negative 21.5%Clorox Co. (CLX) stock fell 2.91% on Thursday, closing at $96.73, despite a positive trading session for the broader market. This marks the stock's second consecutive day of losses, underperforming the S&P 500 Index and the Dow Jones Industrial Average.
A two-story, 30,829-square-foot Clorox office building in Bentonville recently sold for $10.3 million to Arkansas entities S B SNF Realty LLC and Keith Drive Realty LLC. The article also details other significant real estate transactions in the region, including an office building in Rogers …
NEW YORK (AP) — Corporate earnings from big U.S. companies and closely-watched jobs reports are among the key updates for Wall Street this week. The latest batch of profit updates and forecasts could help give investors a clearer picture of how and where households …
The South Dakota Investment Council increased its stake in The Clorox Company by 22.8% in the first quarter, purchasing 16,747 shares and bringing its total holdings to 90,333 shares valued at approximately $9.36 million. Despite this institutional buying, analyst sentiment for Clorox remains cautious …
Bank of Nova Scotia significantly reduced its stake in The Clorox Company (NYSE:CLX) by 88.7% in the first quarter, selling over 150,000 shares. Despite this, Clorox exceeded quarterly earnings expectations, reporting an EPS of $1.64 against a consensus of $1.55. Analyst sentiment remains cautious, …
Clorox (CLX) stock appears to be trading at a discount to its fair value, based on both Discounted Cash Flow (DCF) intrinsic value estimates and earnings multiples. The DCF model suggests Clorox is undervalued by approximately 32.9%, while its P/E ratio of 15.9x is …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Clorox stock has had a tough run over the last five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples now …
Sharemaestro market context Price above Trend Line 52 weeks -18.9% · Next-week setup negative 21.5%First Trust Advisors LP reduced its stake in The Clorox Company (NYSE:CLX) by 15.5% in the first quarter of 2026, selling 60,066 shares and retaining 328,132 shares valued at $34 million. Despite this, other institutional investors have increased their holdings, and 78.53% of the …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Recent analyst commentary around Clorox (CLX) has focused on expectations for a sharp year-over-year drop in earnings and revenue for the June 2026 …
Sharemaestro market context Price above Trend Line 52 weeks -18.9% · Next-week setup negative 21.5%This article provides a revenue breakdown for Clorox Company (CXX BX Swiss). It highlights that the company generated 5.64 billion CHF last year, with its Health and Wellness segment being the top performer at 2.14 billion CHF. The United States was the largest geographical …
Analysts expect Clorox (CLX) to report a significant decline in June-quarter earnings of 42.9% year-over-year and a 4.1% revenue decrease, signaling growing skepticism about its near-term profitability. This follows a previous guidance cut for fiscal 2026, reinforcing concerns about cost pressures, category sluggishness, and …
Sharemaestro market context Price above Trend Line 52 weeks -18.9% · Next-week setup negative 21.5%Clorox (NYSE:CLX) experienced unusually heavy trading in put options, with investors purchasing 15,112 put options, significantly exceeding the typical daily volume. This bearish activity comes despite a director's recent share purchase and institutional ownership of 78.53% of the company. Analysts maintain a "Reduce" rating …
Jefferies downgraded Clorox (NYSE:CLX) from Buy to Hold and lowered its price target to $98 from $125 due to soft share trends and a new CEO. The firm expects fiscal 2027 earnings per share guidance to be 6 percentage points below the Street consensus, …
UBS anticipates a quiet fiscal Q4 for Clorox, with investors more focused on the company's fiscal 2027 targets. The bank notes that expected sales and profit softness for Q4 are already priced in, but rising input costs and a pending management transition add uncertainty …
Options data suggests Clorox Co. (NYSE:CLX) shares could move 4.8% following its earnings report on August 3. The company has a mixed history of exceeding or falling short of implied moves, surpassing expectations in five of its last eight announcements. Its stock movements after …
The market expects Clorox (CLX) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence …
Sharemaestro market context Price above Trend Line 52 weeks -18.9% · Next-week setup negative 21.5%Clorox (CLX) is attracting attention after its stock closed at $95.55, leading investors to re-evaluate its valuation. Despite recent weak returns, a new narrative suggests the stock is 9.3% undervalued, with a fair value of $105.29, primarily driven by anticipated long-term operational efficiencies from …
Clorox (NYSE:CLX) is anticipated to release its Q4 2026 earnings after market close on Monday, August 3rd, with analysts forecasting EPS of $1.64 and revenue of $1.91 billion. The company's previous quarter surpassed expectations with an EPS of $1.64 against a $1.55 consensus. Despite …
This article from Investing.com reports on a Form 4 filing for Clorox Co (CLX) on July 24th. Form 4s indicate changes in beneficial ownership of a company's securities by insiders. No specific details of the filing are provided within the article content.
Clorox executive Nina Barton reported a tax-withholding event where 1,681 shares of Common Stock were withheld by the company at $95.69 per share to cover taxes on vesting restricted stock. Following this transaction, Barton directly holds 26,443 shares. This event is a common occurrence …
Clorox's stock performance reflects a gradual recovery of margins following a cyberattack in late 2023, with recent results showing improved profitability and stable demand for its household brands. The company is focusing on cash generation, disciplined capital allocation, and maintaining its dividend, with its …
SEB Asset Management AB has acquired 27,012 shares of The Clorox Company, valued at approximately $2.799 million, according to its latest 13F filing. Other institutional investors also adjusted their holdings in Clorox, and a director recently increased their stake. The article notes recent analyst …
Evercore ISI has lowered its price target for Clorox (CLX) to $98 from $110, while maintaining an "Underperform" rating on the stock. This adjustment reflects a more cautious outlook from the analyst firm regarding the consumer products company. The report indicates a general trend …
The Swiss National Bank increased its holdings in The Clorox Company (NYSE:CLX) by 7.2% during the first quarter, bringing its total ownership to 357,900 shares valued at $37.09 million. Other institutional investors also adjusted their stakes in Clorox, which saw its shares open at …
The California Public Employees Retirement System (CalPERS) recently reduced its stake in The Clorox Company (NYSE:CLX) by 31.6% in the first quarter, now holding 214,794 shares valued at $22.26 million. Despite this reduction, several other institutional investors increased their holdings in Clorox, and a …
The Clorox Company building in Bentonville, Arkansas, has been sold for $10.3 million. The 30,829-square-foot Class A office building serves as the headquarters for Clorox's team working with Walmart and Clorox has renewed its lease on the property. This transaction highlights the strong demand …
Deutsche Bank has increased its price target for Clorox (NYSE: CLX) to $94 from $91, while reiterating a "Hold" rating on the stock. This adjustment comes amidst other analyst revisions for Clorox, with Barclays maintaining an "Underweight" rating and BNP Paribas Exane holding a …
This article highlights Burt's Bees Moisturizing Lip Balm as a key product in The Clorox Company's personal care portfolio, emphasizing its natural-origin ingredients and consistent market performance. It details the product's formulation, market positioning, diverse flavor offerings, and its role as a gateway product …
Barclays has raised its price target for Clorox (NYSE:CLX) to $86.00 from $85.00, while maintaining an "underweight" rating, indicating a potential downside of 10.7% from the previous close. The consensus target price across analysts is $103.40, with most assigning "Hold" or "Sell" ratings. Clorox …
Sharemaestro market context Price above Trend Line 52 weeks -18.9% · Next-week setup negative 21.5%Barclays has increased its price target for Clorox (CLX) to $86 from $85, while maintaining an Underweight rating on the stock. This adjustment comes amidst other analyst revisions, with some firms like BNP Paribas Exane and JPMorgan also adjusting their price targets for the …
Hsbc Holdings PLC reduced its stake in The Clorox Company by 6.1% in the first quarter, selling 24,221 shares and now owning 375,043 shares worth $38.73 million. Other institutional investors have also adjusted their holdings in Clorox, while a company director recently purchased 5,000 …
BNP Paribas Exane has reduced its price target for The Clorox Company (CLX) to $95 from $97, while maintaining a Neutral rating on the stock. This adjustment reflects a recent shift in analyst sentiment, as other firms like UBS and JPMorgan have also revised …
Search by ticker symbol or company name and select a result to open its chart.